Effects of pharmaceutical medications on male fertility
Journal of Reproduction and Infertility. 2012; 13 (1): 3-11
em Inglês
| IMEMR
| ID: emr-163113
ABSTRACT
The number of couples seeking consultation for infertility problems has steadily increased over the past decade, affecting 10%-15% of the sexually active population. Abnormal semen production, a male factor infertility [MFI], is thought to be the cause of up to 50% of all infertilities in developed countries. There are potentially many different causes of male infertility, including hormonal, anatomical, and secondary to exposure to exogenous substances. In many cases of MFI, a definitive cause for abnormalities is never identified. Recently, the research community has given greater attention to identifying causes of MFI ranging from genetic Y chromosome microdeletions to mechanisms of environmental damage on sperm production. Still evolving, is a clear understanding of how many pharmaceutical medications may cause MFI, which is often treatable and reversible. In this review we will out-line the data regarding various pharmaceutical medications that have been investigated as possible causes of MFI
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Bloqueadores dos Canais de Cálcio
/
Antagonistas Adrenérgicos alfa
/
Antirretrovirais
/
Infertilidade Masculina
/
Anticonvulsivantes
/
Antidepressivos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Reprod. Infertil.
Ano de publicação:
2012
Similares
MEDLINE
...
LILACS
LIS